Bristol-Myers Squibb Company News - May 2026

Bristol Myers Squibb Loses Supreme Court Challenge to Medicare Price Negotiations

The U.S. Supreme Court rejected a legal challenge from Bristol Myers Squibb against the Medicare drug price negotiation program on May 18, 2026. This ruling...

Bristol Myers Squibb's first quarter 2026 revenue grew 3% driven by a 12% increase in its Growth Portfolio.

Bristol Myers Squibb reported first quarter 2026 revenue of $11.5 billion, an increase of 3% year-over-year, while non-GAAP EPS declined 12% to $1.58. The...